Breaching HIV's defences
- 10 July 2015
New research from Dr Max Crispin in the Department of Biochemistry and colleagues has confirmed a potential Achilles' heel in HIV that could be exploited for vaccine design against AIDS. The group's studies, published in five papers over the past four months, show that the glycosylation signature of HIV's envelope spike glycoprotein, Env, may be a promising target for vaccine design.
Read more (Department of Biochemistry website)
Model of HIV’s Env protein with sugars shown in green